The Year in Diabetes and Obesity

This second installment of The Year in Diabetes and Obesity review series includes thought-provoking reviews on central nervous system control of glucose and energy metabolism; stearoyl CoA desaturase in obesity and metabolism; circadian disruption and metabolic dysfunction; incretin hormones; metabolic syndrome, adipokines, and dementia; interventions for the prevention or reversal of type 1 diabetes; the role of intestinal microbiome in humans and mice with type 1 diabetes; building smarter and better insulins; RAGEa multi-ligand receptor in chronic diseases; diabetes, cancer risk, and metforminconnections of metabolism and cell proliferation; prevalence of diabetes in Asia; and prioritization of care in adults with diabetes and co-existing chronic conditions. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit http://ordering.onlinelibrary.wiley.com/subs.asp'ref=1749-6632&doi=10.1111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.

Rexford S. Ahima and Alvin C. Powers are the authors of The Year in Diabetes and Obesity, Volume 1243, published by Wiley.